Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Financial Statements

2 Followers

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Financial Overview

Zylox-Tonbridge Medical Technology Co., Ltd. Class H's market cap is currently HK$7.19B. The company's EPS TTM is HK$0.76; its P/E ratio is 27.47; and it has a dividend yield of 0.48%. Zylox-Tonbridge Medical Technology Co., Ltd. Class H is scheduled to report earnings on March 17, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 1.06B	¥ 782.48M	¥ 527.75M	¥ 334.09M	¥ 177.91M
Gross Profit	¥ 762.92M	¥ 559.89M	¥ 384.99M	¥ 252.67M	¥ 131.88M
Operating Income	¥ 196.64M	¥ 60.91M	¥ -156.52M	¥ -208.40M	¥ -212.48M
EBITDA	¥ 231.92M	¥ 65.30M	¥ -41.60M	¥ -86.56M	¥ -208.49M
Net Income	¥ 244.37M	¥ 100.26M	¥ -78.73M	¥ -113.56M	¥ -199.69M
Balance Sheet
Cash & Short-Term Investments	¥ 1.73B	¥ 1.28B	¥ 1.51B	¥ 1.86B	¥ 2.93B
Total Assets	¥ 3.58B	¥ 3.45B	¥ 3.38B	¥ 3.25B	¥ 3.25B
Total Debt	¥ 63.67M	¥ 90.91M	¥ 55.88M	¥ 14.00M	¥ 9.40M
Net Debt	¥ -516.14M	¥ -327.20M	¥ -1.03B	¥ -1.19B	¥ -1.41B
Total Liabilities	¥ 343.98M	¥ 351.56M	¥ 328.32M	¥ 159.54M	¥ 103.61M
Stockholders' Equity	¥ 3.23B	¥ 3.10B	¥ 3.05B	¥ 3.09B	¥ 3.14B
Cash Flow
Free Cash Flow	¥ 268.72M	¥ -17.26M	¥ -92.48M	¥ -236.60M	¥ -205.80M
Operating Cash Flow	¥ 377.07M	¥ 174.08M	¥ 98.44M	¥ -91.32M	¥ -116.21M
Investing Cash Flow	¥ -46.54M	¥ -801.36M	¥ -206.24M	¥ -95.05M	¥ -1.33B
Financing Cash Flow	¥ -168.64M	¥ -41.98M	¥ -11.46M	¥ -30.26M	¥ 2.81B

Currency in CNY

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Debt to Assets

Balance Sheet >

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Cash Flow

Cash Flow >

Zylox-Tonbridge Medical Technology Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >